Literature DB >> 478089

Retinal fluorescein angiography and hemoglobin A1C in borderline diabetes.

N V Nielsen, P N Sorensen, J Ditzel.   

Abstract

In a controlled study fluorescein angiography of the retina and measurements of hemoglobin A1C were carried out in subjects with slightly abnormal two-hour glucose tolerance and controls with normal glucose tolerance. Fluorescent dots were present in 50 per cent of the series with a reduced glucose tolerance. Leakage from retinal vessels was noted in 20 per cent. In the control group fluorescent dots were present in 25 per cent, of whom none showed leakage. In neither of the series did any subject display ophthalmoscopically visible signs of diabetic retinopathy. In the subjects with abnormal glucose tolerance the mean concentration of hemoglobin A1C was 5.88% +/- 1.15 (SD) and in the control group 5.11% +/- 0.85 (SD) (P less than 0.05) . No correlation was demonstrable between the number of fluorescent dots, hemoglobin A1C and age in the group with abnormal glucose tolerance, but a relationship was noticed between a hereditary disposition to diabetes mellitus and presence of fluorescent dots. Smoking appeared not to have any influence. The result of the present study indicates that incipient retinal microvascular changes and evidence of an early breakdown of the blood-retinal barrier may be present in subjects before diabetes becomes manifest.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 478089

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  2 in total

1.  The relationship between glycosylated haemoglobin levels and various degrees of glucose intolerance.

Authors:  A Verrillo; A de Teresa; R Golia; V Nunziata
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

2.  Retinal malperfusion in albuminuric Type 1 diabetes mellitus patients without clinical signs of diabetic retinopathy: a prospective pilot study.

Authors:  Fernando Korn Malerbi; Caio Vinicius Regatieri; João Roberto de Sa; Paulo Henrique Morales; Michel Eid Farah; Sergio Atala Dib
Journal:  Int J Retina Vitreous       Date:  2017-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.